• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩尔定律、颠覆性技术与临床医生。

Moore's Law, disruptive technologies, and the clinician.

作者信息

Vosburgh Kirby G, Newbower Ronald S

机构信息

CIMIT/MGH/Harvard Medical School, Cambridge, MA 02139, USA.

出版信息

Stud Health Technol Inform. 2002;85:8-13.

PMID:15458052
Abstract

The advancement of technical power described by Moore's Law offers great potential for enabling more cost-effective medical devices and systems. However, progress has been slow. Many factors for this failure have been cited, including the anti-rational economic structure of healthcare and the complexity and long time scale of medical development. Christensen et al. suggest that "disruptive technologies" may circumvent some of these difficulties. "Disruptive Technologies" are defined as those that are established in one market, but then penetrate and overwhelm another market. These incursions are accelerated by economic factors, and capitalize on functionality, reliability, and advancements supported by the original market. Christensen has cited many examples from industrial and service businesses, but few examples can be found yet in healthcare. We argue that positive technology impacts in medicine occur most readily when innovators augment the skills of and collaborate with caregivers, rather than seeking to displace them. In the short term, a new approach may improve efficiency or quality. In the longer term, such approaches may obviate human tasks at lower-skill levels, and even permit task automation. One successful example has been the introduction of flexible monitoring for physiologic information. Systems for computer-aided diagnosis, which have failed to impact complex decision making, have succeeded in simpler specialty areas such as the interpretation of EKG's and mammograms, and may do the same with analysis of some pathology images. The next frontier may the operating room, and the adoption of such systemic technologies by caregivers in emergency medicine and general care may then have an even wider "disruptive" effect. Responding to time and cost pressures, and the desire to move care to the patient, other workers, such as radiologists, will drive the trend away from isolated, complex, large-scale devices, and toward integrated, modular, and simpler networked technologies. In summary, technological "push" will continue in the demanding cutting-edge application areas as always, but the "disruption" will occur through wider application of lower-cost technologies, pulled by the users. The capabilities described by Moore's Law will allow the advancements necessary to facilitate this dissemination of capability and its ultimate benefit, so long sought.

摘要

摩尔定律所描述的技术力量的进步为实现更具成本效益的医疗设备和系统提供了巨大潜力。然而,进展一直缓慢。人们列举了许多导致这种失败的因素,包括医疗保健的反理性经济结构以及医学发展的复杂性和长时间跨度。克里斯滕森等人认为,“颠覆性技术”可能会规避其中一些困难。“颠覆性技术”被定义为那些在一个市场中确立,但随后渗透并主导另一个市场的技术。这些入侵会因经济因素而加速,并利用原始市场所支持的功能、可靠性和进步。克里斯滕森列举了工业和服务业的许多例子,但在医疗保健领域尚未发现很多例子。我们认为,当创新者增强护理人员的技能并与他们合作,而不是试图取代他们时,技术对医学的积极影响最容易出现。短期内,一种新方法可能会提高效率或质量。从长远来看,此类方法可能会消除低技能水平的人工任务,甚至实现任务自动化。一个成功的例子是引入了对生理信息的灵活监测。计算机辅助诊断系统虽然未能影响复杂的决策,但在诸如心电图和乳房X光片解读等较简单的专业领域取得了成功,并且在一些病理图像分析方面可能也会如此。下一个前沿领域可能是手术室,急诊医学和普通护理中的护理人员采用此类系统技术可能会产生更广泛的“颠覆性”影响。为了应对时间和成本压力,以及将护理转移到患者身上的愿望,其他工作人员,如放射科医生,将推动远离孤立、复杂、大型设备的趋势,转向集成、模块化和更简单的网络技术。总之技术“推动”将一如既往地在要求苛刻的前沿应用领域继续,但“颠覆”将通过用户拉动的低成本技术的更广泛应用而发生。摩尔定律所描述的能力将实现促进这种能力传播及其长期以来所追求的最终利益所需的进步。

相似文献

1
Moore's Law, disruptive technologies, and the clinician.摩尔定律、颠覆性技术与临床医生。
Stud Health Technol Inform. 2002;85:8-13.
2
Future perspectives for intraoperative MRI.术中磁共振成像的未来展望。
Neurosurg Clin N Am. 2005 Jan;16(1):201-13. doi: 10.1016/j.nec.2004.07.011.
3
Economic evaluation of medical technologies.医学技术的经济评估。
Isr Med Assoc J. 2005 Feb;7(2):67-70.
4
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
5
Computer assisted orthopaedic surgery. Image guided and robotic assistive technologies.计算机辅助骨科手术。图像引导和机器人辅助技术。
Clin Orthop Relat Res. 1998 Sep(354):8-16.
6
[Conditions for introduction and financing of new technologies].[新技术引进与融资的条件]
Ned Tijdschr Geneeskd. 1999 Nov 6;143(45):2229-32.
7
[The operating room of the future].[未来的手术室]
Ned Tijdschr Geneeskd. 2000 Jan 29;144(5):204-10.
8
American Society of Clinical Oncology guidance statement: the cost of cancer care.美国临床肿瘤学会指导声明:癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
9
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
10
[Telemonitoring of cardiovascular diseases in Germany. Standing position and perspectives].[德国心血管疾病的远程监测。现状与展望]
Herz. 2007 Dec;32(8):641-9. doi: 10.1007/s00059-007-3050-8.

引用本文的文献

1
[Are there technological advances in minimally invasive surgery and who will pay them?].[微创手术有哪些技术进步,以及谁来为此买单?]
Chirurg. 2007 Jun;78(6):519-24. doi: 10.1007/s00104-007-1357-x.